Tim-3+T-bet+Tumor-Specific Th1 Cells Colocalize with and Inhibit Development and Growth of Murine Neoplasms-Reference-Cited by-同舟云学术

Tim-3+T-bet+Tumor-Specific Th1 Cells Colocalize with and Inhibit Development and Growth of Murine Neoplasms

Published:2005-01-20 Issue:3 Volume:174 Page:1405-1415
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Simmons William J.,Koneru Mythili,Mohindru Mani,Thomas Rajan,Cutro Scott,Singh Parul,DeKruyff Rosemarie H.,Inghirami Giorgio,Coyle Anthony J.,Kim Byung S.,Ponzio Nicholas M.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference52 articles.

1. Immunotherapy: past, present and future

2. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

3. Tumor-Specific CD4+T Cells Have a Major “Post-Licensing” Role in CTL Mediated Anti-Tumor Immunity

4. Superantigens related to B cell hyperplasia

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Donkey milk inhibits tumor growth by inducing apoptosis, pyroptosis and modulation of Th1/Th2 responses in a 4T1 murine breast cancer model;Journal of Functional Foods;2024-07

2. CTLA-4 antibody ipilimumab negatively affects CD4+ T-cell responses in vitro;Cancer Immunology, Immunotherapy;2019-07-22

3. T-cell immunoglobulin mucin-3 expression in invasive ductal breast carcinoma: Clinicopathological correlations and association with tumor infiltration by cytotoxic lymphocytes;Molecular and Clinical Oncology;2017-08-03

4. Role of TIM-3 in ovarian cancer;Clinical and Translational Oncology;2017-03-29

5. Reversing T Cell Dysfunction for Tumor Immunotherapy;Novel Immunotherapeutic Approaches to the Treatment of Cancer;2016